Skip to main content

Advertisement

SpringerLink
Log in

Addressing Sphincter Dysfunction in the Female with Neurogenic Lower Urinary Tract Dysfunction

  • Reconstructed Bladder Function & Dysfunction (M Kaufman, Section Editor)
  • Published:
Current Bladder Dysfunction Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Neurogenic sphincter dysfunction in females will be discussed with reference to both foundational and contemporary research with an emphasis on tools for urologic management. The article will focus on both conservative and surgical options for patients broadly characterized with underactive or overactive sphincter dysfunction.

Recent Findings

There is limited recently published prospective data to guide management; however, there exist several insightful retrospective studies to guide practice.

Summary

The bulk of literature for the management of sphincter dysfunction for this complex patient population remains retrospective, and choice of intervention continues to rely upon individual patient characteristics and goals of care to maintain safety and quality of life.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Griffiths D, Derbyshire S, et al. Brain control of normal and overactive bladder. J Urol. 2005;174:1862–7.

    PubMed  Google Scholar 

  2. Wein AJ, Kavoussi LR, Partin AW, Peters CA (2016) Physiology and pharmacology of the bladder and urethra. In: Campbell-Walsh Urology. Eleventh edition., Elsevier.

  3. Fowler CJ, Griffiths D, de Groat WC. The neural control of micturition. Nat Rev Neurosci. 2008;9(6):453–66.

    CAS  PubMed  PubMed Central  Google Scholar 

  4. DeLancey JO. Anatomy and physiology of urinary continence. Clin Obstet Gynecol. 1990;33(2):298–307.

    CAS  PubMed  Google Scholar 

  5. Gajewski JB, Schurch B, Hamid R, et al. An International Continence Society (ICS) report on the terminology for adult neurogenic lower urinary tract dysfunction (ANLUTD). Neurourol Urodyn. 2017:1–10.

  6. Wein AJ, Kavoussi LR, Partin AW, Peters CA. Pathophysiology and classification of lower urinary tract dysfunction: overview. In: Campbell-Walsh Urology. Eleventh edition., Elsevier, 2016.

  7. McGuire EJ, Woodside JR, Borden TA, Weiss RM. Prognostic value of urodynamic testing in myelodysplastic patients. J Urol. 1981;126(2):205–9.

    CAS  PubMed  Google Scholar 

  8. Wein AJ, Kavoussi LR, Partin AW, Peters CA. Neuromuscular dysfunction of the lower urinary tract. Campbell-Walsh Urology. Eleventh edition., Elsevier: In; 2016.

    Google Scholar 

  9. Blaivas JG, Sinha HP, Zayed AA, et al. Detrusor–external sphincter dyssynergia. J Urol. 1981;125:542–4.

    CAS  PubMed  Google Scholar 

  10. Stoffel JT. Detrusor sphincter dyssynergia: a review of physiology, diagnosis, and treatment strategies. Transl Androl Urol. 2016;5(1):127–35.

    PubMed  PubMed Central  Google Scholar 

  11. Wein AJ, Kavoussi LR, Partin AW, Peters CA. Urodynamic and video-urodynamic evaluation of the lower urinary tract. In: Campbell-Walsh Urology. Eleventh edition., Elsevier, 2016.

  12. Grape HH, Dedering A, Jonasson AF. Retest reliability of surface electromyography on the pelvic floor muscles. Neurourol Urodyn. 2013;32:215–23.

    Google Scholar 

  13. Palma JA, Norcliffe-Kaufmann L, Kaufmann H. Diagnosis of multiple system atrophy. Auton Neurosci Basic Clin. 2018;211:15–25.

    Google Scholar 

  14. Jellinger KA. Multiple system atrophy: an oligodendroglioneural synucleinopathy. J Alzheimers Dis. 2018;62:1141–79.

    CAS  PubMed  PubMed Central  Google Scholar 

  15. McDonald C, Winge K, Burn DJ. Lower urinary tract symptoms in Parkinson’s disease: prevalence, aetiology and management. Parkinsonism Relat Disord. 2017;35:8–16.

    PubMed  Google Scholar 

  16. Chen Z, Li G, Liu J. Autonomic dysfunction in Parkinson’s disease: implications for pathophysiology, diagnosis, and treatment. Neurobiol Dis. 2019;104700.

  17. Araki I, Kitahara M, Oida T, Kuno S. Voiding dysfunction and Parkinson’s disease: urodynamic abnormalities and urinary symptoms. J Urol. 2000;164(5):1640–3.

    CAS  PubMed  Google Scholar 

  18. Sakakibara, R, Kishi, M, Ogawa, E, Tateno, F, Uchiyama, T, Yamamoto, T, Yamanishi, T. Bladder, bowel, and sexual dysfunction in Parkinson’s disease. Parkinson’s Disease 2011:1–21.

  19. Gupta A, Rashmi-Krishnan UK, Nageshkumar S, Pal PK, Khanna M, Taly AB. Urinary symptoms in patients with Parkinson’s disease and progressive supranuclear palsy: urodynamic findings and management of bladder dysfunction. Ann Indian Acad Neurol. 2019;22(4):432–6.

    PubMed  PubMed Central  Google Scholar 

  20. Savard E, Declemy A, Coindreau V, Babany F, Chesnel C, Charlanes A, et al. Self-intermittent-catheterization and urinary retention in Parkinsonian syndromes. Prog Urol. 2018;28(17):987–92.

    CAS  PubMed  Google Scholar 

  21. Godmer M, Guinet-Lacoste A, Charvier K, Luauté J, Rode G, Soler JM, et al. Is there any obstruction other than prostatic obstruction in idiopathic Parkinson’s disease? Prog Urol. 2019;29(11):579–85.

    CAS  PubMed  Google Scholar 

  22. Pavlakis AJ, Siroky MB, Goldstein I, Krane RJ. Neurourologic findings in Parkinson’s disease. J Urol. 1983;129(1):80–3.

    CAS  PubMed  Google Scholar 

  23. Dorsher PT, McIntosh PM. Neurogenic bladder. Adv Urol. 2012;2012:816274.

    PubMed  PubMed Central  Google Scholar 

  24. Stoffel JT. Chronic urinary retention in multiple sclerosis patients: physiology, systematic review of urodynamic data, and recommendations for care. Urol Clin North Am. 2017;44:429–39.

    PubMed  Google Scholar 

  25. Lemack GE, Frohman E, Ramnarayan P. Women with voiding dysfunction secondary to bladder outlet dyssynergia in the setting of multiple sclerosis do not demonstrate significantly elevated intravesical pressures. Urology. 2007;69:893–7.

    PubMed  Google Scholar 

  26. Jazayeri SB, Ataeepour M, Rabiee H, Motevalian SA, Saadat S, Vaccaro AR, et al. Prevalence of spinal cord injury in Iran: a 3-source capture-recapture study. Neuroepidemiology. 2015;45:28–33.

    PubMed  Google Scholar 

  27. Taweel WA, Seyam R. Neurogenic bladder in spinal cord injury patients. Res Reports Urol. 2015;7:85–99.

    Google Scholar 

  28. Sivkov AV, Romikh VV, Egorov AA. Use of alpha1-adrenergic blockaders in voiding disorders in women. Urologiia. 2002;5:52–63.

    Google Scholar 

  29. Kilicarslan H, Ayan S, Vuruskan H, Gokce G, Gultekin EY. Treatment of detrusor sphincter dyssynergia with baclofen and doxazosin. Int Urol Nephrol. 2006;38:537–41.

    CAS  PubMed  Google Scholar 

  30. Medical Advisory Secretariat. Intrathecal baclofen pump for spasticity: an evidence-based analysis. Ontario Health Technology Assessment Series. 2005:5(7).

  31. Del Fabro AS, Mejia M, Nemunaitis G. An investigation of the relationship between autonomic dysreflexia and intrathecal baclofen in patients with spinal cord injury. J Spinal Cord Med. 2018;41(1):102–5.

    PubMed  Google Scholar 

  32. Lloyd LK, Kuhlemeier KV, Fine PR, et al. Initial bladder management in spinal cord injury: does it make a difference? J. Urol. 1986;135:523–7.

    CAS  PubMed  Google Scholar 

  33. Lapides J, Diokno AC, Silber SJ, Lowe BS. Clean, intermittent self-catheterization in the treatment of urinary tract disease. J Urol. 1972;107:458–61.

    CAS  PubMed  Google Scholar 

  34. Lamin E, Newman DK. Clean intermittent catheterization revisited. Int Urol Nephrol. 2016;48:931–9.

    PubMed  Google Scholar 

  35. Chartier-Kastler E, Denys P. Intermittent catheterization with hydrophilic catheters as a treatment of chronic neurogenic urinary retention. Neurourol Urodyn. 2011;30:21–31.

    PubMed  Google Scholar 

  36. Blok B, Castro-Diaz D, Del Popolo G, Groen J, Hamid R, Karsenty G, Kessler TM, Pannek J. Members of the EAU neuro-urology guidelines 2019: Retrieved from https://uroweb.org/guideline/neuro-urology/

  37. Virseda-Chamorro M, Salinas-Casado J, Rubio-Hidalgo E, et al. Risk factors of urethral diverticula in male patients with spinal cord injury. Spinal Cord. 2015;53(11):803–6.

    CAS  PubMed  Google Scholar 

  38. Stern JA, Clemens JQ. Osteomyelitis of the pubis: a complication of a chronic indwelling catheter. Urology. 2003;61(2):462.

    PubMed  Google Scholar 

  39. McGuire EJ, Savastano J. Comparative urological outcome in women with spinal cord injury. J Urol. 1986;135:730–1.

    CAS  PubMed  Google Scholar 

  40. Bennett CJ, Young MN, Adkins RH, Diaz F. Comparison of bladder management complication outcomes in female spinal cord injury patients. J Urol. 1995;153:1458–60.

    CAS  PubMed  Google Scholar 

  41. Larsen LD, Chamberlin DA, Khonsari F, Ahlering TA. Retrospective analysis of urologic complications in male patients with spinal cord injury managed with and without indwelling urinary catheters. Urology. 1997;50:418–22.

    CAS  PubMed  Google Scholar 

  42. Weld KJ, Dmochowski RR. Effect of bladder management on urological complications in spinal cord injured patients. J Urol. 2000;163:768–72.

    CAS  PubMed  Google Scholar 

  43. Katsumi HK, Kalisvaart JF, Ronningen LD, Hovey RM. Urethral versus suprapubic catheter: choosing the best bladder management for male spinal cord injury patients with indwelling catheters. Spinal Cord. 2010;48:325–9.

    CAS  PubMed  Google Scholar 

  44. Mitsui T, Minami K, Furuno T, Morita H, Koyanagi T. Is suprapubic cystostomy an optimal urinary management in high quadriplegics?. A comparative study of suprapubic cystostomy and clean intermittent catheterization. Eur Urol. 2000;38(4):434–8.

    CAS  PubMed  Google Scholar 

  45. Gui-Zhong L, Li-Bo M. Bladder cancer in individuals with spinal cord injuries: a meta-analysis. Spinal Cord. 2017;55(4):341–5.

    CAS  PubMed  Google Scholar 

  46. Ismail S, Karsenty G, Chartier-Kastler E, Cussenot O, Compérat E, Rouprêt M, et al. Prevalence, management, and prognosis of bladder cancer in patients with neurogenic bladder: a systematic review. Neurourol Urodyn. 2018;37:1386–95.

    PubMed  Google Scholar 

  47. Perrouin-Verbe B, Labat JJ, Richard I, Mauduyt de la Greve I, Buzelin JM, Mathe JF. Clean intermittent catheterisation from the acute period in spinal cord injury patients. Long term evaluation of urethral and genital tolerance. Paraplegia. 1995;33:619–24.

    CAS  PubMed  Google Scholar 

  48. Wyndaele JJ, Maes D. Clean intermittent self-catheterization: a 12-year follow-up. J Urol. 1990;143:906–8.

    CAS  PubMed  Google Scholar 

  49. Perkash I, Giroux J. Clean intermittent catheterization in spinal cord injury patients: a follow-up study. J Urol. 1993;149:1068–71.

    CAS  PubMed  Google Scholar 

  50. Moore KN, Fader M, Getliffe K. Long term bladder management by intermittent catheterisation in children and adults. Cochrane Database Syst Rev. 2007;4:CD006008.

    Google Scholar 

  51. Taskinen S, Fagerholm R, Ruutu M. Patient experience with hydrophilic catheters used in clean intermittent catheterization. J Pediatr Urol. 2008;4:367–71.

    PubMed  Google Scholar 

  52. Stensballe J, Loom D, Nielsen PN, Tvede M. Hydrophilic-coated catheters for intermittent catheterisation reduce urethral microtrauma: a prospective, randomised, participant-blinded, crossover study of three different types of catheters. Eur Urol. 2005;48:978–83.

    CAS  PubMed  Google Scholar 

  53. Hedlund H, Hjelmas K, Jonsson O, et al. Hydrophilic versus non-coated catheters for catheterization. Scand J Urol Nephrol. 2001;35:49–53.

    CAS  PubMed  Google Scholar 

  54. Vapnek JM, Maynard FM, Kim J. A prospective randomized trial of the Lofric hydrophilic coated catheter versus conventional plastic catheter for clean intermittent catheterization. J Urol. 2003;169:994–8.

    PubMed  Google Scholar 

  55. Cardenas DD, Moore KN, Dannels-McClure A, Scelza WM, Graves DE, Brooks M, et al. Intermittent catheterization with a hydrophilic-coated catheter delays urinary tract infections in acute spinal cord injury: a prospective, randomized, multicenter trial. PM&R. 2011;3:408–17.

    Google Scholar 

  56. Li L, Ye W, Ruan H, Yang B, Zhang S, Li L. Impact of hydrophilic catheters on urinary tract infections in people with spinal cord injury: systematic review and meta-analysis of randomized controlled trials. Arch Phys Med Rehabil. 2013;94:782–7.

    PubMed  Google Scholar 

  57. • Calisto FCFS, Vilar FO, Lustosa ES. et al. A new bladder-emptying method in females with neurogenic bladder: a randomized, phase II trial. Neurourol. Urodyn. 2019:38:1721–1727. Six-month outcomes of randomized control trial of intra-urethral self-retaining device against CIC in female NLUTD patients.

  58. Gor RA, Elliott SP. Surgical management of neurogenic lower urinary tract dysfunction. Urol Clin North Am. 2017;44:475–90.

    PubMed  Google Scholar 

  59. Ross JC, Gibbon NOK, Damanski M. Division of the external urethral sphincter in the treatment of paraplegic bladder. A preliminary report on a new procedure. Brit J Urol. 1958;30:204–12.

    CAS  PubMed  Google Scholar 

  60. Dykstra DD, Sidi AA, Scott AB, Pagel JM, Goldish GD. Effects of botulinum A toxin on detrusor-sphincter dyssynergia in spinal cord injury patients. J Urol. 1988;139:919–22.

    CAS  PubMed  Google Scholar 

  61. Dykstra DD, Sidi AA. Treatment of detrusor-sphincter dyssynergia with botulinum A toxin: a double-blind study. Arch Phys Med Rehabil. 1990;71:24–6.

    CAS  PubMed  Google Scholar 

  62. Utomo E, Groen J and Blok BFM: Surgical management of functional bladder outlet obstruction in adults with neurogenic bladder dysfunction. Cochrane Database Syst Rev 2014.

  63. Mehta S, Hill D, Foley N, Hsieh J, Ethans K, Potter P, et al. A meta-analysis of botulinum toxin sphincteric injections in the treatment of incomplete voiding after spinal cord injury. Arch Phys Med Rehabil. 2012;93:597–603.

    PubMed  Google Scholar 

  64. Kuo HC. Satisfaction with urethral injection of botulinum toxin A for detrusor sphincter dyssynergia in patients with spinal cord lesion. Neurourol Urodyn. 2008;27:793–6.

    CAS  PubMed  Google Scholar 

  65. Kuo HC. Botulinum A toxin urethral injection for the treatment of lower urinary tract dysfunction. J Urol. 2003;170:1908–12.

    CAS  PubMed  Google Scholar 

  66. Chen YH, Kuo HC. Botulinum A toxin treatment of urethral sphincter pseudodyssynergia in patients with cerebrovascular accidents or intracranial lesions. Urol Int. 2004;73(2):156–62.

    CAS  PubMed  Google Scholar 

  67. • Jiang YH, Chen SF, Jhang JF, et al. Therapeutic effect of urethral sphincter onabotulinumtoxinA injection for urethral sphincter hyperactivity. Neurourol. Urodyn. 2018;37:2651–7 A retrospective study of Botox for neurogenic sphincter dysfunction with focus on patient-reported outcomes and uroflowmetry.

    CAS  PubMed  Google Scholar 

  68. de Sèze M, Petit H, Gallien P, de Sèze MP, Joseph PA, Mazaux JM, et al. Botulinum a toxin and detrusor sphincter dyssynergia: a double-blind lidocaine-controlled study in 13 patients with spinal cord disease. Eur Urol. 2002;42(1):56–62.

    PubMed  Google Scholar 

  69. Gallien P. Placebo controlled, randomised, double blind study of the effects of botulinum A toxin on detrusor sphincter dyssynergia in multiple sclerosis patients. J Neurol Neurosurg Psychiatry. 2005;76(12):1670–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  70. Hu M, Lai S, Zhang Y, Liu M, Wang J. Sacral neuromodulation for lower urinary tract dysfunction in spinal cord injury: a systematic review and meta-analysis. Urol Int. 2019;103:337–43.

    PubMed  Google Scholar 

  71. Goldman HB, Lloyd JC, Noblett KL, Carey MP, Castaño Botero JC, Gajewski JB, et al. International Continence Society best practice statement for use of sacral neuromodulation. Neurourol Urodyn. 2018;37:1823–48.

    PubMed  Google Scholar 

  72. Yang CC. Bladder management in multiple sclerosis. Phys Med Rehabil Clin N Am. 2013;24(4):673–86.

    CAS  PubMed  Google Scholar 

  73. Aharony SM, Lam O, Corcos J. Treatment of lower urinary tract symptoms in multiple sclerosis patients: review of the literature and current guidelines. Can Urol Assoc J. 2017;11(3–4):110–E115.

    Google Scholar 

  74. Levy ME, Elliott SP. Reconstructive techniques for creation of catheterizable channels: tunneled and nipple valve channels. Transl Androl Urol. 2016;5:136–44.

    PubMed  PubMed Central  Google Scholar 

  75. Kalkan S, Jaffe WI, Simma-Chiang V, Li ESW, Blaivas JG. Long term results of augmentation cystoplasty and urinary diversion in multiple sclerosis. Can J Urol. 2019;26(3):9774–80.

    PubMed  Google Scholar 

  76. Szymanski KM, et al. Additional surgeries after bladder augmentation in patients with spina bifida in the 21st century. J Urol. 2020;203:1–7.

    Google Scholar 

  77. Zachoval R, Pitha J, Medova E, Heracek J, Lukes M, Zalesky M, et al. Augmentation cystoplasty in patients with multiple sclerosis. Urol Int. 2003;70(1):21–6.

    PubMed  Google Scholar 

  78. Vian E, Soustelle L, Viale S, Costa P. A technique of continent vesicostomy with ileocystoplasty: study of 32 patients. Prog Urol. 2009;19(2):116–21.

    CAS  PubMed  Google Scholar 

  79. • Husmann DA, Viers BR. Neurogenic bladder: management of the severely impaired patient with complete urethral destruction: ileovesicostomy, suprapubic tube drainage or urinary diversion – is one treatment modality better than another? Translational Andrology and Urology. 2020;9(1):132–41 This paper reviews NLUTD patients managed with BNC with ileovesicostomy, BNC with SPT, or cystectomy with enteric conduit diversion and finds ileovesicostomy is associated with a significantly increased incidence of urosepsis and late surgical complications.

    PubMed  PubMed Central  Google Scholar 

  80. • Myers JB, et al. Patient reported bladder related symptoms and quality of life after spinal cord injury with different bladder management strategies. J. Urol. 2019;202:574–84 This study in SCI patients measured quality of life with different bladder management strategies including surgery.

    PubMed  Google Scholar 

  81. Akakpo W, Chartier-Kastler E, Joussain C, Denys P, Lubetzki C, Phé V. Outcomes of ileal conduit urinary diversion in patients with multiple sclerosis. Neurourol Urodyn. 2020:1–7.

  82. Ventimiglia B, Morana C, Lopes M, Lopes L, Savoca F, Consoli C, et al. Disorders of micturition in neurological patients. A clinical study of 786 patients. J Neuro. 1998;245(3):173–7.

    CAS  Google Scholar 

  83. Koyanagi T, Morita H, Taniguchi K, Kubota M, Shinno Y, Takamatsu T. Neurogenic urethra: clinical relevance of isolated neuropathic dysfunction of the urethra, and the denervation supersensitivity of the urethra revisited. Eur Urol. 1988;15:77–83.

    CAS  PubMed  Google Scholar 

  84. Blaivas JG, and Chancellor MB: Cauda equina and pelvic plexus injury. In Chancellor MB, and Blaivas JG (eds): Practical neurourology. Boston: Butterworth-Heinemann 1995:155–164.

  85. McGuire, EJ: Clinical evaluation and treatment of neurogenic vesical dysfunction. In Leslie JA (eds): International perspectives in urology. Williams & Wilkins Baltimore 1984: 43–56.

  86. Cibula D, Sláma J, Velechovská P, Fischerova D, Zikán M, Pinkavová I, et al. Factors affecting spontaneous voiding recovery after radical hysterectomy. Int J Gynecol Cancer. 2010;20:685–90.

    PubMed  Google Scholar 

  87. Cheung F, Sandhu JS. Voiding dysfunction after non-urologic pelvic surgery. Curr Urol Rep. 2018;19:1–6.

    Google Scholar 

  88. Derks M, Van Der Velden J, Frijstein MM, Vermeer WM, Stiggelbout AM, Roovers JPWR, et al. Long-term pelvic floor function and quality of life after radical surgery for cervical cancer. Int J Gynecol Cancer. 2016;26:1538–43.

    PubMed  Google Scholar 

  89. Raspagliesi F, Bogani G, Spinillo A, Ditto A, Bogliolo S, Casarin J, et al. Introducing nerve-sparing approach during minimally invasive radical hysterectomy for locally-advanced cervical cancer: a multi-institutional experience. Eur J Surg Oncol. 2017;43:2150–6.

    PubMed  Google Scholar 

  90. Sun X-L,Wang H-B,Wang Z-Q,Cao T, Yang X, Han JS, Wu YF, Reilly KH, Wang JL Effect of transcutaneous electrical stimulation treatment on lower urinary tract symptoms after class III radical hysterectomy in cervical cancer patients: study protocol for a multicentre, randomized controlled trial. BMC Cancer; 2017:17:416.

  91. Daniels IR, Woodward S, Taylor FG, Raja A, Toomey P. Female urogenital dysfunction following total mesorectal excision for rectal cancer. World J Surg Oncol. 2006;4:6.

    PubMed  PubMed Central  Google Scholar 

  92. Kyo K, Sameshima S, Takahashi M, Furugori T, Sawada T. Impact of autonomic nerve preservation and lateral node dissection on male urogenital function after total mesorectal excision for lower rectal cancer. World J Surg. 2006;30:1014–9.

    PubMed  Google Scholar 

  93. Lange MM, Van De Velde CJH. Urinary and sexual dysfunction after rectal cancer treatment. Nat Rev Urol. 2011;8:51–7.

    PubMed  Google Scholar 

  94. Lange MM, Maas CP, Marijnen CAM, Wiggers T, Rutten HJ, Kranenbarg EK, et al. Urinary dysfunction after rectal cancer treatment is mainly caused by surgery. Br J Surg. 2008;95:1020–8.

    CAS  PubMed  Google Scholar 

  95. Grise P, Thurman S. Urinary incontinence following treatment of localized prostate cancer. Cancer Control. 2001;8:532–9.

    CAS  PubMed  Google Scholar 

  96. Marks LB, Carroll PR, Dugan TC, Anscher MS. The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy. Int J Radiat Oncol Biol Phys. 1995;31:1257–80.

    CAS  PubMed  Google Scholar 

  97. Sterk P, Shekarriz B, Günter S, Nolde J, Keller R, Bruch HP, et al. Voiding and sexual dysfunction after deep rectal resection and total mesorectal excision: prospective study on 52 patients. Int J Color Dis. 2005;20:423–7.

    Google Scholar 

  98. Miyazato M, Kadekawa K, Kitta T, Wada N, Shimizu N, de Groat WC, et al. New frontiers of basic science research in neurogenic lower urinary tract dysfunction. Urol Clin N Am. 2017;44(3):491–505.

    Google Scholar 

  99. Miyazato M, Ashikari A. Therapeutic new targets for stress urinary incontinence in the central nervous system. Japanese Pharmacology Journal. 2020;155(1):16–9.

    Google Scholar 

  100. Verhoef M, Lurvink M, Barf HA, Post MWM, van Asbeck FWA, Gooskens RHJM, et al. High prevalence of incontinence among young adults with spina bifida: description, prediction and problem perception. Spinal Cord. 2005;43:331–40.

    CAS  PubMed  Google Scholar 

  101. Bowman RM, McLone DG, Grant JA, Tomita T, Ito JA. Spina bifida outcome: a 25-year prospective. Pediatr Neurosurg. 2001;34:114–20.

    CAS  PubMed  Google Scholar 

  102. Bomalaski MD, Teague JL, Brooks B. The long-term impact of urological management on the quality of life of children with spina bifida. J Urol. 1995;154:778–81.

    CAS  PubMed  Google Scholar 

  103. Malone PS, Wheeler RA, Williams JE. Continence in patients with spina bifida: long term results. Arch Dis Child. 1994;70:107–10.

    CAS  PubMed  PubMed Central  Google Scholar 

  104. Cameron AP, Wallner LP, Tate DG, Sarma AV, Rodriguez GM, Clemens JQ. Bladder management after spinal cord injury in the United States 1972 to 2005. J Urol. 2010;184:213–7.

    PubMed  Google Scholar 

  105. Li H, Westney OL. Injection of urethral bulking agents. Urol Clin N Am. 2019;46(1):1–15.

    Google Scholar 

  106. Maggiore LR, et al. Urethral bulking agents versus other surgical procedures for the treatment of female stress urinary incontinence: a systematic review and meta-analysis. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2015;189:48–54.

    Google Scholar 

  107. El-Azab AS, El-Nashar SA. Midurethral slings versus the standard pubovaginal slings for women with neurogenic stress urinary incontinence. Int. Urogynecol. J Pelvic Floor Dysfunct. 2014;26:427–32.

    Google Scholar 

  108. Hamid R, Khastgir J, Arya M, Patel HRH, Shah PJR. Experience of tension-free vaginal tape for the treatment of stress incontinence in females with neuropathic bladders. Spinal Cord. 2003;41:118–21.

    CAS  PubMed  Google Scholar 

  109. Abdul-Rahman A, Attar KH, Hamid R, Shah PJR. Long-term outcome of tension-free vaginal tape for treating stress incontinence in women with neuropathic bladders. BJU Int. 2010;106:827–30.

    PubMed  Google Scholar 

  110. Mcguire EJ, Lytton B. Pubovaginal sling procedure for stress incontinence. J Urol. 1978;119(1):82–4.

    CAS  PubMed  Google Scholar 

  111. •• Phe V, Léon P, Granger B, et al. Stress urinary incontinence in female neurological patients: long-term functional outcomes after artificial urinary sphincter (AMS 800TM) implantation. Neurourol Urodyn. 2017;36(3):764–9 Long-term AUS outcomes specifically on ISD in female patients with NLUTD.

    PubMed  Google Scholar 

  112. Stoffel JT, McGuire EJ. Outcome of urethral closure in patients with neurologic impairment and complete urethral destruction. Neurourol Urodyn. 2006;25:19–22.

    PubMed  Google Scholar 

  113. Ginger VA. Bladder neck closure and suprapubic tube placement in a debilitated patient population. Neurourol Urodyn. 2010;29:382–6.

    PubMed  Google Scholar 

  114. Shpall AI, Ginsberg DA. Bladder neck closure with lower urinary tract reconstruction: technique and long-term follow-up. J Urol. 2004;172:2296–9.

    PubMed  Google Scholar 

  115. Willis H, Safiano NA, Lloyd LK. Comparison of transvaginal and retropubic bladder neck closure with suprapubic catheter in women. J Urol. 2015;193:196–202.

    PubMed  Google Scholar 

  116. Hou J, Bacsu C, Zimmern PE, et al. 1422 bladder neck closure in women: lessons learned from a tertiary neurogenic bladder clinic. J Urol. 2013;189:e582.

    Google Scholar 

  117. Altaweel WM, Rajih E, Alkhudair W. Interposition flaps in vesicovaginal fistula repairs can optimize cure rate. Urol Ann. 2013;5(4):270–2.

    PubMed  PubMed Central  Google Scholar 

  118. Evans DH, Madjar S, Politano VA, Bejany DE, Lynne CM, Gousse AE. Interposition flaps in transabdominal vesicovaginal fistula repairs: are they really necessary? Urology. 2001;57:670–4.

    CAS  PubMed  Google Scholar 

  119. Delong J, Tighiouart H, Stoffel J. Urinary diversion/reconstruction for cases of catheter intolerant secondary progressive multiple sclerosis with refractory urinary symptoms. J Urol. 2011;185:2201–6.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, University of Michigan, 1500 E. Medical Center Drive, Ann Arbor, MI, 48109-5330, USA

    Javier E. Santiago, Anne P. Cameron & Roberto A. Navarrete

Authors
  1. Javier E. Santiago
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anne P. Cameron
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Roberto A. Navarrete
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Javier E. Santiago.

Ethics declarations

Conflict of Interest

Anne Cameron is a primary investigator for a study by Medtronic and is a speaker for Wellspect.

Javier Santiago and Roberto Navarrete declare that they have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Reconstructed Bladder Function & Dysfunction

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Santiago, J.E., Cameron, A.P. & Navarrete, R.A. Addressing Sphincter Dysfunction in the Female with Neurogenic Lower Urinary Tract Dysfunction. Curr Bladder Dysfunct Rep 15, 142–152 (2020). https://doi.org/10.1007/s11884-020-00597-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11884-020-00597-x

Keywords

Search

Navigation